These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 6203067

  • 1. The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat.
    Neve KA, Marshall JF.
    Neurosci Lett; 1984 Apr 20; 46(1):77-83. PubMed ID: 6203067
    [Abstract] [Full Text] [Related]

  • 2. Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockade.
    Neve KA, Loeschen S, Marshall JF.
    Brain Res; 1985 Mar 11; 329(1-2):225-31. PubMed ID: 3156659
    [Abstract] [Full Text] [Related]

  • 3. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA, Altar CA, Wong CA, Marshall JF.
    Brain Res; 1984 Jun 04; 302(1):9-18. PubMed ID: 6428705
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915
    [Abstract] [Full Text] [Related]

  • 5. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment.
    MacKenzie RG, Zigmond MJ.
    J Neurochem; 1984 Nov 28; 43(5):1310-8. PubMed ID: 6208330
    [Abstract] [Full Text] [Related]

  • 6. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
    Korf J, Sebens JB.
    J Neurochem; 1987 Feb 28; 48(2):516-21. PubMed ID: 2878979
    [Abstract] [Full Text] [Related]

  • 7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 28; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 8. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.
    LaHoste GJ, Marshall JF.
    Brain Res; 1989 Nov 20; 502(2):223-32. PubMed ID: 2531015
    [Abstract] [Full Text] [Related]

  • 9. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.
    Duncan GE, Criswell HE, McCown TJ, Paul IA, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1987 Dec 20; 243(3):1027-34. PubMed ID: 3121842
    [Abstract] [Full Text] [Related]

  • 10. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD, Jenner P, Kelly E, Marsden CD.
    Br J Pharmacol; 1983 Jun 20; 79(2):599-610. PubMed ID: 6418246
    [Abstract] [Full Text] [Related]

  • 11. Unilateral striatal dopamine denervation: reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behaviour.
    Costall B, Kelly ME, Naylor RJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May 20; 326(1):29-35. PubMed ID: 6433208
    [Abstract] [Full Text] [Related]

  • 12. The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
    Traub M, Wagner HR, Hassan M, Jackson-Lewis V, Fahn S.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):147-54. PubMed ID: 3936723
    [Abstract] [Full Text] [Related]

  • 13. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):73-82. PubMed ID: 1321630
    [Abstract] [Full Text] [Related]

  • 14. Effects of estradiol on intact and denervated striatal dopamine receptors and on dopamine levels: a biochemical and behavioral study.
    Di Paolo T, Bédard PJ, Dupont A, Poyet P, Labrie F.
    Can J Physiol Pharmacol; 1982 Mar 07; 60(3):350-7. PubMed ID: 7200388
    [Abstract] [Full Text] [Related]

  • 15. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF, Van het Schip F, Sebens JB, Korf J.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):387-99. PubMed ID: 6436037
    [Abstract] [Full Text] [Related]

  • 16. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission.
    Savasta M, Dubois A, Benavidès J, Scatton B.
    Neurosci Lett; 1988 Feb 15; 85(1):119-24. PubMed ID: 2834672
    [Abstract] [Full Text] [Related]

  • 17. Changes of the striatal 3H-spiperone binding 3-6 weeks after nigrostriatal denervation and after two years.
    Guerin B, Silice C, Mouchet P, Feuerstein C, Demenge P.
    Life Sci; 1985 Sep 09; 37(10):953-61. PubMed ID: 3162072
    [Abstract] [Full Text] [Related]

  • 18. Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites.
    Kozlowski MR, Neve KA, Grisham JE, Marshall JF.
    Brain Res; 1983 May 16; 267(2):301-11. PubMed ID: 6409351
    [Abstract] [Full Text] [Related]

  • 19. Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
    Lai H, Kazi MS, Carino MA, Horita A.
    Life Sci; 1982 Mar 08; 30(10):821-6. PubMed ID: 7200179
    [Abstract] [Full Text] [Related]

  • 20. Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentation.
    Oberlander C, Boissier JR.
    J Pharmacol; 1983 Mar 08; 14(4):401-4. PubMed ID: 6423905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.